Abstract
Human medicines European public assessment report (EPAR): Elebrato Ellipta, fluticasone furoate / umeclidinium / vilanterol, Pulmonary Disease, Chronic Obstructive, Date of authorisation: 15/11/2017, Revision: 4, Status: Authorised
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have